FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955107301> ?p ?o ?g. }

• W2955107301 endingPage "2050" @default.
• W2955107301 startingPage "2041" @default.
• W2955107301 abstract "PURPOSE In the randomized open-label phase III OVHIPEC trial, the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery (CRS) improved recurrence-free and overall survival in patients with stage III ovarian cancer. We studied the cost effectiveness of the addition of HIPEC to interval CRS in patients with ovarian cancer. PATIENTS AND METHODS We constructed a Markov health-state transition model to measure costs and clinical outcomes. Transition probabilities were derived from the OVHIPEC trial by fitting survival distributions. Incremental cost-effectiveness ratio (ICER), expressed as euros per quality-adjusted life-year (QALY), was calculated from a Dutch societal perspective, with a time horizon of 10 years. Univariable and probabilistic sensitivity analyses were conducted to evaluate the decision uncertainty. RESULTS Total health care costs were €70,046 (95% credibility interval [CrI], €64,016 to €76,661) for interval CRS compared with €85,791 (95% CrI, €78,766 to €93,935) for interval CRS plus HIPEC. The mean QALY in the interval CRS group was 2.12 (95% CrI, 1.66 to 2.64 QALYs) and 2.68 (95% CrI, 2.11 to 3.28 QALYs) in the interval CRS plus HIPEC group. The ICER amounted to €28,299/QALY. In univariable sensitivity analysis, the utility of recurrence-free survival and the number of days in the hospital affected the calculated ICER most. CONCLUSION On the basis of the trial data, treatment with interval CRS and HIPEC in patients with stage III ovarian cancer was accompanied by a substantial gain in QALYs. The ICER is below the willingness-to-pay threshold in the Netherlands, indicating interval CRS and HIPEC is cost effective for this patient population. These results lend additional support for reimbursing the costs of treating these patients with interval CRS and HIPEC in countries with comparable health care systems." @default.
• W2955107301 created "2019-07-12" @default.
• W2955107301 creator A5002461644 @default.
• W2955107301 creator A5016117849 @default.
• W2955107301 creator A5016399717 @default.
• W2955107301 creator A5031176507 @default.
• W2955107301 creator A5037041908 @default.
• W2955107301 creator A5037246030 @default.
• W2955107301 creator A5039468626 @default.
• W2955107301 creator A5044960311 @default.
• W2955107301 creator A5048535376 @default.
• W2955107301 creator A5058424202 @default.
• W2955107301 creator A5067550035 @default.
• W2955107301 creator A5071780971 @default.
• W2955107301 creator A5072317673 @default.
• W2955107301 creator A5074957985 @default.
• W2955107301 creator A5074963799 @default.
• W2955107301 creator A5075879058 @default.
• W2955107301 creator A5080868486 @default.
• W2955107301 creator A5083085080 @default.
• W2955107301 creator A5087782965 @default.
• W2955107301 creator A5088241536 @default.
• W2955107301 creator A5089235633 @default.
• W2955107301 date "2019-08-10" @default.
• W2955107301 modified "2023-10-14" @default.
• W2955107301 title "Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial" @default.
• W2955107301 cites W1937476324 @default.
• W2955107301 cites W1964453404 @default.
• W2955107301 cites W1982735211 @default.
• W2955107301 cites W1986485564 @default.
• W2955107301 cites W1989570498 @default.
• W2955107301 cites W1997625372 @default.
• W2955107301 cites W2029630138 @default.
• W2955107301 cites W2080084883 @default.
• W2955107301 cites W2112182168 @default.
• W2955107301 cites W2126499930 @default.
• W2955107301 cites W2146461887 @default.
• W2955107301 cites W2166310305 @default.
• W2955107301 cites W2334353679 @default.
• W2955107301 cites W2337377794 @default.
• W2955107301 cites W2557867537 @default.
• W2955107301 cites W2620203957 @default.
• W2955107301 cites W2737389832 @default.
• W2955107301 cites W2770527543 @default.
• W2955107301 cites W2784597821 @default.
• W2955107301 cites W2786590497 @default.
• W2955107301 cites W2787553551 @default.
• W2955107301 cites W2803602511 @default.
• W2955107301 cites W2889779979 @default.
• W2955107301 doi "https://doi.org/10.1200/jco.19.00594" @default.
• W2955107301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31251694" @default.
• W2955107301 hasPublicationYear "2019" @default.
• W2955107301 type Work @default.
• W2955107301 sameAs 2955107301 @default.
• W2955107301 citedByCount "35" @default.
• W2955107301 countsByYear W29551073012019 @default.
• W2955107301 countsByYear W29551073012020 @default.
• W2955107301 countsByYear W29551073012021 @default.
• W2955107301 countsByYear W29551073012022 @default.
• W2955107301 countsByYear W29551073012023 @default.
• W2955107301 crossrefType "journal-article" @default.
• W2955107301 hasAuthorship W2955107301A5002461644 @default.
• W2955107301 hasAuthorship W2955107301A5016117849 @default.
• W2955107301 hasAuthorship W2955107301A5016399717 @default.
• W2955107301 hasAuthorship W2955107301A5031176507 @default.
• W2955107301 hasAuthorship W2955107301A5037041908 @default.
• W2955107301 hasAuthorship W2955107301A5037246030 @default.
• W2955107301 hasAuthorship W2955107301A5039468626 @default.
• W2955107301 hasAuthorship W2955107301A5044960311 @default.
• W2955107301 hasAuthorship W2955107301A5048535376 @default.
• W2955107301 hasAuthorship W2955107301A5058424202 @default.
• W2955107301 hasAuthorship W2955107301A5067550035 @default.
• W2955107301 hasAuthorship W2955107301A5071780971 @default.
• W2955107301 hasAuthorship W2955107301A5072317673 @default.
• W2955107301 hasAuthorship W2955107301A5074957985 @default.
• W2955107301 hasAuthorship W2955107301A5074963799 @default.
• W2955107301 hasAuthorship W2955107301A5075879058 @default.
• W2955107301 hasAuthorship W2955107301A5080868486 @default.
• W2955107301 hasAuthorship W2955107301A5083085080 @default.
• W2955107301 hasAuthorship W2955107301A5087782965 @default.
• W2955107301 hasAuthorship W2955107301A5088241536 @default.
• W2955107301 hasAuthorship W2955107301A5089235633 @default.
• W2955107301 hasBestOaLocation W29551073012 @default.
• W2955107301 hasConcept C112930515 @default.
• W2955107301 hasConcept C121608353 @default.
• W2955107301 hasConcept C126322002 @default.
• W2955107301 hasConcept C141071460 @default.
• W2955107301 hasConcept C143998085 @default.
• W2955107301 hasConcept C146357865 @default.
• W2955107301 hasConcept C151730666 @default.
• W2955107301 hasConcept C168563851 @default.
• W2955107301 hasConcept C2779458272 @default.
• W2955107301 hasConcept C2780427987 @default.
• W2955107301 hasConcept C29456083 @default.
• W2955107301 hasConcept C2994223192 @default.
• W2955107301 hasConcept C3019080777 @default.
• W2955107301 hasConcept C44249647 @default.
• W2955107301 hasConcept C535046627 @default.

• next